{"data":[{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"New Enterprise Associates 16, L.P.","reportingCik":"0001694560","personType":"PN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"NEA Partners 16, L.P.","reportingCik":"0001712881","personType":"PN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"NEA 16 GP, LLC","reportingCik":"0001712882","personType":"OO","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Forest Baskett","reportingCik":"0001277631","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Ali Behbahani","reportingCik":"0001613867","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Carmen Chang","reportingCik":"0001746342","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Anthony A. Florence, Jr.","reportingCik":"0001559827","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Mohamad H. Makhzoumi","reportingCik":"0001630226","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Scott D. Sandell","reportingCik":"0001237289","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001072613-25-000858","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001094038","issuerName":"Marker Therapeutics, Inc.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-13","reportingPerson":"Paul Walker","reportingCik":"0001553150","personType":"IN","sharesOwned":1670081,"percentOfClass":9.9,"filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001172661-25-005191","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001094038","issuerName":"MARKER THERAPEUTICS, INC.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":1280952,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001172661-25-005191","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001094038","issuerName":"MARKER THERAPEUTICS, INC.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":1280952,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"},{"accessionNo":"0001172661-25-005191","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001094038","issuerName":"MARKER THERAPEUTICS, INC.","ticker":"MRKR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":1280952,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr"}],"updatedAt":"2026-11-04T07:13:00.759Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mrkr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}